ORIGINAL ARTICLE
Activation of the P38-MSK1 axis in colorectal adenocarcinoma determines a good prognostic outcome
More details
Hide details
1
Assistant professor of Pathology, Faculty of Medicine, Minia University, Minia, Egypt
2
Consultant of Onco-surgery, Minia Oncology Centre, Minia, Egypt
3
Assistant professor of Tropical Medicine, Faculty of Medicine, Minia University, Minia, Egypt
4
Biomedical Scientist, UCL Institute for Liver and Digestive Health, Royal Free London NHS Foundation Trust, London, UK
Submission date: 2020-09-25
Final revision date: 2020-11-04
Acceptance date: 2020-11-16
Publication date: 2021-05-31
Pol J Pathol 2021;72(1):39-47
KEYWORDS
TOPICS
ABSTRACT
Colorectal cancer (CRC) is the third most common cancer worldwide and is associated with a high level of mortality and morbidity. In this study we evaluate expression of p-p38 and p-MSK1 in CRC and determine whether there is an association between expression of these markers and any clinicopathologic parameters that could be of prognostic value.
Expression of p-p38, p-MSK1 and ki-67 were examined by immunohistochemistry in 135 archival CRC cases and the findings were correlated with the patient clinicopathological data.
P-p38 and p-MSK1 were expressed at high level in 58.5 % and 60.7% of CRC cases respectively. A statistically significant negative correlation was found between expression of p-p38 and Ki-67 (p < 0.001, r = –0.63) and between p-MSK1 and Ki-67 expression (p < 0.001, r = –0.61). The majority of CRC cases expressing high levels of p-p38 also expressed high levels of p-MSK1 and this correlation was highly significant (p < 0.001, r = 0.863). The high expression of p-p38 and p-MSK1 was also significantly associated with low Dukes and TNM stage. The elevated expression of p-38 and p-MSK1 in CRC was associated with a good prognosis and prolonged overall survival (p < 0.001, each).
Our finding showed that activation of the p38-MSK1 axis determines a good outcome in CRC.
REFERENCES (51)
1.
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians 2015; 65: 87-108.
2.
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424.
3.
Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer; Available from:
https://gco.iarc.fr/today, Accessed 02 November 2018. .
4.
Grossi V, Peserico A, Tezil T, Simone C. p38α MAPK pathway: A key factor in colorectal cancer therapy and chemoresistance. World J Gastroenterol 2014; 20: 9744-9758. .
5.
Wu Q, Yuan S, Ren C, et al. Oridonin upregulates PTEN through activating p38 MAPK and Inhibits Proliferation in Human Colon Cancer Cells Oncol Rep 2016; 35: 3341-3348.
6.
Vermeulen L, Vanden B, Beck I, et al. The versatile role of MSKs in transcriptional regulation. Trends Biochem Sci 2009; 34: 311-318.
7.
Dhillon A, Hagan S, Rath O, Kolch W. MAP kinase signalling pathways in cancer. Oncogene 2007; 26; 3279-3290.
8.
Greenberg A, Basu S, Hu J, et al. Selective p38 activation in human non-small cell lung cancer. Am J Respir Cell Mol Biol 2002; 26: 558-564.
9.
Iyoda K, Sasaki Y, Horimoto M, et al. Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinoma. Cancer 2003; 97: 3017-3026.
10.
Suarez-Cuervo C, Merrell M, Watson L, et al. Breast cancer cells with inhibition of p38alpha have decreased MMP-9.
11.
activity and exhibit decreased bone metastasis in mice. Clin Exp Metastasis 2004; 21: 525-533.
12.
Khandrika L, Lieberman R, Koul S, et al. Hypoxia-associated p38 mitogen-activated protein kinase-mediated androgen receptor activation and increased HIF-1alpha levels contribute to emergence of an aggressive phenotype in prostate cancer. Oncogene 2009; 28: 1248-1260. .
13.
Kumar B, Koul S, Petersen J, et al. p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity. Cancer Res 2010; 70: 832-841.
14.
Fu X, Fan X, Hu J, Zou H, et al. Overexpression of MSK1 is associated with tumor aggressiveness and poor prognosis in colorectal cancer. Dig Liver Dis 2017; 49: 683-691.
15.
Yang S, Miah A, Sales K, et al. Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment. Int J Oncol 2011; 78: 1695-1702.
16.
Kim H, Lee K, Cho Y, et al. Mitogen- and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformation. Cancer Res 2008; 68: 2538-2547.
17.
Li B, Wan Z, Huang G, et al. Mitogen- and stress-activated Kinase 1 mediates Epstein-Barr virus latent membrane protein 1-promoted cell transformation in nasopharyngeal carcinoma through its induction of Fra-1 and c-Jun genes. BMC Cancer 2015; 15: 390.
18.
Reyes D, Ballare C, Castellano G, et al. Activation of mitogen- and stress-activated kinase 1 is required for proliferation of breast cancer cells in response to estrogens or progestins. Oncogene 2014; 33: 1570-1580.
19.
Pérez-Cadahía B, Drobic B, Espino P, et al. Role of MSK1 in the malignant phenotype of Ras-transformed mouse fibroblasts. J Biol Chem 2011; 286: 42-49.
20.
Roux P, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 2004; 68: 320-344.
21.
Wiggin G, Soloaga A, Foster J, et al. MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts. Mol Cell Biol 2002; 22: 2871-2881.
22.
Ronkina N, Menon M, Schwermann J, et al. Stress induced gene expression: a direct role for MAPKAP kinases in transcriptional activation of immediate early genes. Nucleic Acids Res 2011; 39: 2503-2518.
23.
Khan S, Amnekar R, Khade B, Barreto et al. p38-MAPK/MSK1-mediated overexpression of histone H3 serine 10 phosphorylation defines distance-dependent prognostic value of negative resection margin in gastric cancer. Clin Epigenetics 2016; 8: 88.
24.
Ordonez-Moran P, Larriba M, Pálmer H, et al. RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells.
25.
J Cell Biol 2008; 183: 697-710.
26.
Schluter C, Duchrow M, Wohlenberg C, et al. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins.
27.
J Cell Biol 1993; 123: 513-522.
28.
Luo Z, Zhu M, Zhang Z, et al. Increased expression of Ki-67 is a poor prognostic marker for colorectal cancer patients: a meta-.
29.
analysis. BMC Cancer 2019; 19: 123. .
30.
Mohamed F, Al-Jehani R, Minogue S, et al. Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma. Liver Int 2015; 35: 1063-1076.
31.
von Wasielewski R, Klopper K, Luck H, et al. Improvement of breast cancer grading in punch biopsies: grading with the Ki-67 marker. Pathologe 2006; 27: 337-345.
32.
Siegel R, Miller K, Fedewa S, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin 2017; 67: 177-193.
33.
Aguirre-Ghiso J, Estrada Y, Liu D, Ossowski L. ERK(MAPK) activity as adeterminant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res 2003; 63: 1684-1695.
34.
Qi X, Tang J, Pramanik R, et al. p38 MAPK activation selectively induces cell death in K-ras-mutated human colon cancer cells through regulation of vitamin D receptor. J Biol Chem 2004; 279: 22138-22144.
35.
Simone C. Signal-dependent control of autophagy and cell death in colorectal cancer cell: the role of the p38 pathway. Autophagy 2007; 3: 468-471.
36.
Johnston S, Ahmad D, Aleskandarany M, et al. R Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair. BMC Cancer 2018; 18: 1027. .
37.
Canovas B, Igea A, Sartori A, et al. Targeting p38alpha increases DNA damage, chromosome instability, and the anti-tumoral response to Taxanes in breast Cancer cells. Cancer Cell 2018; 33: 1094-1110.
38.
Brancho D, Tanaka N, Jaeschke A, et al. Mechanism of p38 MAP kinase activation in vivo. Genes Dev 2003; 17: 1969-1978.
39.
Bulavin DV, Phillips C, Nannenga B, et al. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat Genet 2004; 36: 343-350.
40.
Esteva F, Sahin A, Smith T, et al. Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma. Cancer 2004; 100: 499-506.
41.
Saika S, Okada Y, Miyamoto T, et al. Role of p38 MAP kinase in regulation of cell migration and proliferation in healing corneal epithelium. Invest Ophthalmol Vis Sci 2004; 45: 100-109.
42.
Dey H, Liu Z. Phosphorylation of p68 RNA helicase by p38 MAP kinase contributes to colon cancer cells apoptosis induced by oxaliplatin. BMC Cell Biol 2012; 13: 27.
43.
Madia F, Grossi V, Peserico A, Simone C. Updates from the Intestinal Front Line: Autophagic Weapons against Inflammation and Cancer. Cells 2012; 1: 535-557.
44.
Strippoli R, Benedicto I, Foronda M, et al. p38 maintains E-cadherin expression by modulating TAK1–NF-κB during epithelial-to-mesenchymal transition. J Cell Sci 2010; 123: 4321-4331.
45.
Lee S, Lee T, Park E. Immunohistochemical analysis of nuclear factor, p38, and cyclin D1 proteins in premalignant lesions and carcinomas of the colorectal mucosa. Korean J Gastroenterol 2008; 52: 359-367.
46.
Fan X, Wan X, Fu X, et al. Phosphorylated p38, a negative prognostic biomarker, complements TNM staging prognostication in colorectal cancer. Tumour Biol 2014; 35: 10487-10495.
47.
Pu X, Storr S, Ahmad N, et al. High nuclear MSK1 is associated with longer survival in breast cancer patients. J Cancer Res Clin Oncol 2018; 144: 509-517.
48.
Terazawa S, Nakano M, Yamamoto A, Imokawa G. Mycosporine-like amino acids stimulate hyaluronan secretion by up-regulating hyaluronan synthase 2 via activation of the p38/MSK1/CREB/c-Fos/AP-1 axis. J Biol Chem 2020; 295: 7274-7288.
49.
Imokawa G. Intracellular Signaling Mechanisms Involved in the Biological Effects of the Xanthophyll Carotenoid Astaxanthin to Prevent the Photo-aging of the Skin in a Reactive Oxygen Species Depletion-independent Manner: The Key Role of Mitogen and Stress-activated Protein Kinase 1. Photochem Photobiol 2019; 95: 480-489.
50.
Yu T, Yu Q, Chen X, et al. Exclusive enteral nutrition protects against inflammatory bowel disease by inhibiting NFκB activation through regulation of the p38/MSK1 pathway. Int.
51.
J Mol Med 2018; 42: 1305-1316.